ARB’s (and probably aliskiren) are particularly effective at suppressing aldosterone production, so a patient with a low or low-normal renin level and a high or high-normal aldosterone level while taking an ARB probably has primary aldosteronism, for the purposes of adjusting medical therapy. The gene discussed is REN; the disease is primary aldosteronism.